These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
222 related items for PubMed ID: 23135882
21. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors. Jin M, Hwang SM, Davies AJ, Shin Y, Bae JS, Lee JH, Lee EB, Song YW, Park K. Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887 [Abstract] [Full Text] [Related]
23. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients. Koo NY, Li J, Hwang SM, Choi SY, Lee SJ, Oh SB, Kim JS, Lee EB, Song YW, Park K. Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835 [Abstract] [Full Text] [Related]
24. Autoantibodies against the Second Extracellular Loop of M3R Do neither Induce nor Indicate Primary Sjögren's Syndrome. Chen Y, Zheng J, Huang Q, Deng F, Huang R, Zhao W, Yin J, Song L, Chen J, Gao X, Liu Z, Petersen F, Yu X. PLoS One; 2016 Jun; 11(2):e0149485. PubMed ID: 26901532 [Abstract] [Full Text] [Related]
30. Effect of Antimuscarinic Autoantibodies in Primary Sjögren's Syndrome. Kim N, Shin Y, Choi S, Namkoong E, Kim M, Lee J, Song Y, Park K. J Dent Res; 2015 May; 94(5):722-8. PubMed ID: 25784251 [Abstract] [Full Text] [Related]
31. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome. Asashima H, Tsuboi H, Takahashi H, Hirota T, Iizuka M, Kondo Y, Matsui M, Matsumoto I, Sumida T. Arthritis Rheumatol; 2015 May; 67(8):2213-25. PubMed ID: 25891013 [Abstract] [Full Text] [Related]
32. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches. Dawson LJ, Allison HE, Stanbury J, Fitzgerald D, Smith PM. Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609 [Abstract] [Full Text] [Related]
33. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder. Wang F, Jackson MW, Maughan V, Cavill D, Smith AJ, Waterman SA, Gordon TP. Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387 [Abstract] [Full Text] [Related]
34. Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndrome. Roescher N, Kingman A, Shirota Y, Chiorini JA, Illei GG. Ann Rheum Dis; 2011 Jan; 70(1):235-6. PubMed ID: 20498204 [Abstract] [Full Text] [Related]
36. [The clinical significance of autoantibodies against acetylcholine muscarinic 3 receptor in primary Sjögren's syndrome]. Wu Y, Li MT, Zhao Y, Feng S, Su L, Dong Y. Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):563-5. PubMed ID: 19035167 [Abstract] [Full Text] [Related]
38. Muscarinic type 3 receptor autoantibodies are associated with anti-SSA/Ro autoantibodies in Sjögren's syndrome. Zuo J, Williams AE, Park YJ, Choi K, Chan AL, Reeves WH, Bubb MR, Lee YJ, Park K, Stewart CM, Cha S. J Immunol Methods; 2016 Oct; 437():28-36. PubMed ID: 27460476 [Abstract] [Full Text] [Related]
40. An experimental protocol for the fractionation and 2DE separation of HeLa and A-253 cell lysates suitable for the identification of the individual antigenic proteome in Sjögren's syndrome. Nginamau ES, Maehle BO, Jonsson R. Autoimmunity; 2011 Dec; 44(8):652-63. PubMed ID: 21875379 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]